Cart
sales@molnova.com
Ciglitazone
CAS No. 74772-77-3
Ciglitazone( —— )
Catalog No. M33630 CAS No. 74772-77-3
Ciglitazone (ADD 3878) is a potent and selective PPARγ agonist (EC50: 3 μM) and oral hypoglycemic agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 86 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCiglitazone
-
NoteResearch use only, not for human use.
-
Brief DescriptionCiglitazone (ADD 3878) is a potent and selective PPARγ agonist (EC50: 3 μM) and oral hypoglycemic agent.
-
DescriptionCiglitazone is a potent and selective PPARγ agonist (EC50=3 μM). Ciglitazone inhibits proliferation and differentiation of th17 cells. Ciglitazone is a hypoglycemic agent orally active in the obese-hyperglycemic animal models. Ciglitazone induces apoptosis accompanied by activation of p38 MAPK and nuclear translocation of apoptosis inducing factor (AIF) in opossum kidney (OK) renal epithelial cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR | Apoptosis | p38 MAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number74772-77-3
-
Formula Weight333.45
-
Molecular FormulaC18H23NO3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (299.90 mM; Ultrasonic )
-
SMILESCC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Willson TM, et al. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem. 1996;39(3):665-668. ?
molnova catalog
related products
-
K-111
K-111 (BM-170744) is an orally available peroxisome proliferator-activated receptor (PPAR)-alpha agonist and insulin enhancer for the study of obesity-type diabetes mellitus and the metabolic syndrome.
-
Reglitazar
Reglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.
-
Clofibric acid
Clofibric acid is a PPARα agonist and hypolipidemic agent.
